The metabolic effect of antenatal corticosteroid therapy

Human Reproduction Update

Volumn 6, Issue 2, 2000, Pages 169-176

  Ogueh, O ^a   Johnson, M R ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Antenatal corticosteroids; Dexamethasone; Fetal growth; Metabolic effects; Respiratory distress

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; PLACENTAL PEPTIDE HORMONE;

CLINICAL TRIAL; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; DRUG SAFETY; FEMALE; FETUS LUNG MATURATION; GLUCOSE TOLERANCE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMATURITY; META ANALYSIS; METABOLISM; MOTHER; NEWBORN MORBIDITY; NEWBORN MORTALITY; OSSIFICATION; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW;

EID: 0034031146     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/6.2.169     Document Type: Review

References (93)

1. Adamson, I.Y.R. and King, G.M. (1988) Postnatal development of rat lung following retarded fetal lung growth. Ped. Pulmonology, 4, 230-236.
2. Bell, S.C. (1989) Decidualization and insulin-like growth factor (IGF) binding protein: implications for its role in stromal cell differentiation and the decidual cell in haemochorial placentation. Hum. Reprod., 4, 125-130.
3. Bennett, L., Kozuma, S., McGarrigle, H.H.G. and Hanson, M.A. (1999) Temporal changes in fetal and cardiovascular, behavioural, metabolic and endocrine responses to maternally administered dexamethasone in the late gestation sheep. Br. J. Obstet. Gynaecol., 106, 331-339.
4. Braunstein, G.D., Rasor, J.L., Engvall, E. and Wade, M.E. (1980) Interrelationships of human chorionic gonadotropin, human placental lactogen, and pregnancy-specific beta 1-glycoprotein throughout normal human gestation. Am. J. Obstet. Gynecol., 138, 1205-1213.
5. Broditsky, R.S., Reyes, F.I., Winter, J.S.D. and Faiman, C. (1975) Serum human chorionic gonadotropin and progesterone pattern in the last trimester of pregnancy: relationship to fetal sex. Am. J. Obstet. Gynecol., 121, 238-241.
6. Bunton, T.E. and Plopper, C.G. (1984) Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am. J. Obstet. Gynecol., 148, 203-215.
7. Caporali, R., Gentile, S., Caprotti, M. and Montecucco, C. (1991) Serum osteocalcin (bone Gla-protein) and steroid osteoporosis in rheumatoid arthritis. J. Rheumatol., 18, 148-149.
8. Carson, S., Taeusch, H.W.J. Jr and Avery, M. (1973) Inhibition of lung cell division after hydrocortisone injection into fetal rabbits. J. Appl. Physiol., 34, 660-663.
9. Caufriez, A. and Copinschi, G. (1986) Somatomedins and steroids. Hormone Res., 24, 185-188.
10. Clark, P.M. (1998) Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur. J. Ped., 157 (Suppl. 1), S7-10.
11. Clemmons, D.R. (1991) Insulin-like growth factor binding proteins: roles in regulating IGF physiology. J. Dev. Physiol., 15, 105-110.
12. Cox, D.B., Fraser, M. and Challis, J.R.G. (1999a) Placental development following maternal dexamethasone treatment during early pregnancy. J. Soc. Gynecol. Invest., 6, 119.
13. Cox, D.B., Brubaker, P., Fraser, M. et al. (1999b) The effect of maternal dexamethasone during early pregnancy on fetal growth, HPA development and the control of glucose homeostasis. J. Soc. Gynecol. Invest., 6, 251.
14. Crowley, P. (1992) Antenatal corticosteroid therapy: A meta-analysis of randomised trials, 1972-94. Am. J. Obstet. Gynecol., 173, 322-335.
15. Cutroneo, K.R., Rokowski, R. and Counts, D.F. (1981) Glucocorticoids and collagen synthesis: comparison of in vivo and cell culture studies. Collagen Related Res., 1, 557-568.
16. Dodic, M., May, C.N., Wintour, E.M. and Coghlan, J.P. (1998) An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci. (Colch.), 94, 149-155.
17. Elliot, J.P. and Radan, T.G. (1995) The effect of corticosteroid administration on uterine activity and prterm labor in high order multiple gestations. Obstet. Gynecol., 160, 247-251.
18. Fant, M., Munro, H. and Moses, A.C. (1986) An autocrine/paracrine role for insulin-like growth factors in the regulation of human placental growth. J. Clin. Endocrinol. Metab., 63, 499-505.
19. Ford, L.R., Willi, S.M., Hollis, B.W. and Wright, N.M. (1997) Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. J. Pediatrics, 131, 722-726.
20. French, N., Hagan, R., Evans, S. et al. (1999) Repeated antenatal corticosteroids: growth and early childhood outcome. Obstet. Gynecol., 180, 114-121.
21. Godschalk, M.F. and Downs, R.W. (1988) Effects of short-term glucocorticoids on serum osteocalcin in healthy young men. J. Bone Mineral Res., 3, 113-115.
22. Gourmelen, M., Girard, F. and Binoux, M. (1982) Serum somatomedin/ insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy. J. Clin. Endocrinol. Metab., 54, 885-892.
23. Hendershott, C.M., Dullien, V. and Goodwin, T.M. (1999) Serial betamethasone administration: effect on maternal salivary estriol levels. Am. J. Obstet. Gynecol., 180, S219-222.
24. Haning, R.V. Jr, Choi, L., Kiggens, A.J. et al. (1982) Effects of dibutyryl adenosine 3′, 5′-monophosphate, luteinizing hormone-releasing hormone, and aromatase inhibitor on simultaneous outputs of progesterone, 17 beta-estradiol, and human chorionic gonadotropin by term placental explants. J. Clin. Endocrinol. Metab., 55, 213-218.
25. Haning, R.V., Curet, L.B., Poole, W.K. et al. (1989) Effects of fetal sex and dexamethasone on preterm maternal serum concentrations of human chorionic gonadotropin, progesterone, estrone, estradiol, and estriol. Am. J. Obstet. Gynecol., 161, 1549-1553.
26. Hills, F.A., English, J. and Chard, T. (1996) Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J. Endocrinol., 148, 303-309.
27. Hobson, B. and Wide, L. (1974) Chorionic gonadotrophin in the human placenta in relation to the sex of the foetus at term. J. Endocrinol., 60, 75-80.
28. Holly, J.M.P., Biddlecombe, R.A., Dunger, D.B. et al. (1988) Circadian variation of GH-dependent IGF-binding protein in diabetes mellitus and its relationship to insulin. Clin. Endocrinol., 29, 667-675.
29. Hossenlopp, P., Seurin, D., Segovia, B. et al. (1987) Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture. Eur. J. Biochem., 170, 133-142.
30. Hristic, M., Kalafatic, D., Plecas, B. and Manojlovic, M. (1997) The effect of prolonged dexamethasone treatment of pregnant rats on the perinatal development of the adrenal gland of their offspring. J. Exp. Zool., 279, 54-61.
31. Johnson, B.H., Ayala Torres, S., Chan, L.N. et al. (1997) Glucocorticoid/ oxysterol-induced DNA lysis in human leukemic cells. J. Steroid Biochem. Mol. Biol., 61, 35-45.
32. Jones, S.A., Brooks, A.N. and Challis, J.R.G. (1989) Steroids modulate corticotrophin-releasing factor production in human fetal membranes and placenta. J. Clin. Endocrinol. Metab., 68, 825-830.
33. Jones, J.L., D'Ercole, J., Carnacho-Hubner, C. and Clemmons, D.R. (1991) Phosphorylation of IGFBP-1 in cell culture and in vivo effects on affinity for IGP-1. Proc. Natl Acad. Sci. USA, 88, 7481-7485.
34. Jones, J.L., Busby, W.H., Wright, G. and Clemmons, D.R. (1993) Human IGFBP-1 is phosphorylated on three serine residues: effects of site directed mutagenesis of the major phosphoserine. Growth Reg., 1, 31-40.
35. Kauppila, A., Jouppila, P., Karvonen, P. et al. (1976) Effects of Dexamethasone on Blood Levels of ACTH, Cortisol, Progesterone, Estradiol and Estriol during Late Pregnancy. Int. J. Gynaecol. Obstet., 14, 177-181.
36. Khastgir, G. and Studd, J. (1994) Pregnancy-associated osteoporosis. Br. J. Obstet. Gynaecol., 101, 836-838.
37. Khastgir, G., Studd, J.W.W., King, H. et al. (1996) Bone changes during pregnancy in women with normal and low bone density. Curr. Res. Osteoporosis Bone Mineral Meas., 4, 21-22.
38. Korebrits, C., Yu, D.H.T., Ramirez, M.M. et al. (1998) Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br. J. Obstet. Gynaecol., 105, 556-561.
39. Laan, R.F.J.M., van Riel, P.L.C.M., van de Putte, L.B.A. et al. (1993) Low dose prednisolone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomised controlled study. Ann. Int. Med., 119, 963-968.
40. Lalou, C., Lassarre, C. and Binoux, M. (1996) A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology, 137, 3206-3212.
41. Lalou, C., Sawamura, S., Segovia, B. et al. (1997) Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity. C.R. Acad. Science III, 320, 621-628.
42. Lamont, R.F., Dunlop, P.D., Levene, M.I. and Elder, M.G. (1983) Use of glucocorticoids in pregnancies complicated by severe hypertension and proteinuria. Br. J. Obstet. Gynaecol., 90, 199-202.
43. Lange, A.P. and Anthonsen, H. (1980) Serum levels of human placental lactogen during and after prenatal dexamethasone therapy. Acta Obstet. Gynecol. Scand., 59, 111-114.
44. Lewitt, M.S. and Baxter, R.C. (1989) Regulation of growth hormone-independent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver explants. J. Clin. Endocrinol. Metab., 69, 246-252.
45. Liggins, G.C. and Howie, R.N. (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants. Paediatrics, 50, 515-525.
46. Luo, J.M. and Murphy, L.J. (1989) Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology, 125, 165-171.
47. Luo, J., Reid, R.E. and Murphy, L.J. (1990) Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology, 127, 1456-1462.
48. Manojlovic, M., Kalafatic, D., Hristic, M. et al. (1998) Treatment of pregnant females with dexamethasone influences postnatal development of the adrenal medulla. Anat. Anzac, 180, 131-135.
49. Manu, T. and Chou, J.Y. (1981) Regulation of human chorionic gonadotropin synthesis in cultured human placental cells by glucocorticoids. Endocrinology, 109, 888-892.
50. Massaro, D., Teich, N., Maxwell, S. et al. (1985) Postnatal development of alveoli. Regulation and evidence of a critical period in rats. J. Clin. Invest., 76, 1297-1305.
51. Matsuzaki, N., Neki, R., Sawai, K. et al. (1995) Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer. J. Clin. Endocrinol. Metab., 80, 2912-2917.
52. McMahon, M., Gerich, J. and Rizza, R. (1988) Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab. Rev., 4, 17-30.
53. Melkko, J., Niemi, S. and Risteli, J. (1990) Radioimmunoassay of the carboxy terminal propeptide of human type I procollagen. Clin. Chem., 36, 1328-1332.
54. Miell, J.P., Taylor, A.M., Jones, J. et al. (1993) Effect of dexamethasone on immunoreactive and bioreactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J. Endocrinol., 136, 525-533.
55. Mosier, H.D. Jr, Jansons, R.A., Hill, R.R. and Dearden, L.C. (1976) Cartilage sulfation and serum somatomedin in rats during and after cortisone-induced growth arrest. Endocrinology, 99, 580-598.
56. Nelson-Piercy, C. and De Swiet, M. (1994) Corticosteroids for the treatment of hyperemesis gravidarum. Br. J. Obstet. Gynaecol., 101, 1013-1015.
57. Ng, P.C., Wong, G.W., Lam, C.W. et al. (1997a) Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. J. Clin. Endocrinol. Metab., 82, 2429-2432.
58. Ng, P.C., Wong, G.W., Lam, C.W. et al. (1997b) Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. J. Clin. Endocrinol. Metab., 82, 3548-3552.
59. Nielsen, H.K., Brixen, K., Kassem, M. and Mosekilde, L. (1991) Acute effect of 1, 25-dihydroxyvitamin D3, prednisone, and 1, 25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals. J. Bone Min. Res., 6, 435-441.
60. Nyirenda, M.J., Lindsay, R.S., Kenyon, C.J. et al. (1998) Glucocorticoid exposure in late gestationpermanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest., 101, 2174-2181.
61. Ogueh, O., Hills, F., Chard, T. and Johnson, M.R. (1998a) Antenatal dexamethasone administration does not affect maternal circulating levels of IGFBP-1. Hum. Reprod., 13, 1714-1716.
62. Ogueh, O., Khastiger, G., Studd, J.W. et al. (1998b) The effect of dexamethasone on maternal bone markers. Br. J. Obstet. Gynaecol., 105, 551-555.
63. Ogueh, O., Jones, J., Mitchell, H. et al. (1999a) Effect of antenatal dexamethasone administration on plasma levels of human chorionic gonadotrophin, oestradiol and progesterone. Hum. Reprod., 14, 303-306.
64. Ogueh, O., Khastgir, G., Studd, J. et al. (1999b) Postpartum Bone Mineral Density following antenatal corticosteroid therapy. Br. J. Obstet. Gynaecol., 106, 1093-1095.
65. Ogueh, O., Jones, J., Alaghband-Zadeh, J. et al. (2000) Effect of antenatal dexamethasone on plasma levels of IGF. Hum. Reprod., 15, in press.
66. Ohrlander, S., Gennser, G., Batra, S. and Lebech, P. (1977) Effects of Betamethasone administration on Estrone, Estradiol-17β, and Progesterone in Maternal Plasma and amniotic fluid. Obstet. Gynecol., 49, 148-153.
67. Oikarinen, A., Autio, P., Vuori, J. et al. (1992) Systemic glucocorticoid treatment decreases serum concentrations of carboxy terminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br. J. Dermatol., 126, 172-178.
68. Oikarinen, A.I., Uitto, J. and Oikarinen, J. (1996) Glucocorticoid action on connective tissue: from molecular mechanism to clinical practice. Med. Biol., 64, 221-230.
69. Ooi, G.T. (1990) Insulin-like growth factor-binding proteins (IGFBPs): more than just 1, 2, 3. Mol. Cell. Endocrinol., 71, C39-43.
70. Packe, G.E., Douglas, J.G., McDonald, A.F. et al. (1992) Bone density in asthamatic patients taking high dose inhaled and intermittent systemic corticosteroids. Thorax, 47, 414-417.
71. Pracyk, J.B., Seidler, F.J., McCook, E.C. and Slotkin, T.A. (1992) Pituitary-thyroid axis reactivity to hyper and hypothyroidism in the perinatal period: ontogeny of regulation and longterm programming of response. J. Dev. Physiol., 18, 105-109.
72. Price, W.A., Stiles, A.D., Moats-Staats, B.M. and D'Ercole, A.J. (1992) Gene expression of insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology, 130, 1424-1432.
73. Prummel, M.F., Wiersinga, W.M., Lips, P. et al. (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. J. Clin. Endocrinol. Metab., 72, 382-386.
74. Puistola, U., Risteli, L., Kauppila, A. et al. (1993) Markers of type I and type III collagen synthesis in serum as indicators of tissue growth-during pregnancy. J. Clin. Endocrinol. Metab., 77, 178-182.
75. Risteli, J., Elomaa, I., Niemi, S. et al. (1993) Radioimmunoassay for the pyridoline cross-linked carboxy terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin. Chem., 39, 635-640.
76. Rutanen, E.M., Koistinen, R., Wahlstrom, T. et al. (1985) Synthesis of placental protein 12 by human decidua. Endocrinology, 116, 1304-1309.
77. Salafia, C.M., Ghidini, A., Stone, J. et al. (1997) Do antenatal steroids affect placental histopathology? [(Abstr. no. 138]. Am. J. Obstet. Gynecol., 176, S49.
78. Sawai, K., Matsuzaki, N., Kameda, T. et al. (1995) Leukemia inhibitory factor produced at the fetomaternal interface stimulates chorionic gonadotropin production: its possible implication during pregnancy, including implantation period. J. Clin. Endocrinol. Metab., 80, 1449-1456.
79. Scharf, J., Ramadori, G., Braulke, T. and Hartmann H. (1996) Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulin-like growth factor, and growth hormone. Hepatology, 23, 818-827.
80. Sinclair, J. (1994) Discussion of Crowley's meta-analysis of randomised controlled trials of antenatal corticosteroids for prevention of respiratory distress syndrome. In Report of the Consensus Development Conference on the Effects of Corticosteroids for Fetal Maturation on Perinatal Outcomes. National Institutes of Health, Bethesda. USA, pp. 95-96.
81. Suikkari, A., Koivisto, V.A., Koistinen, R. et al. (1989) Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor binding protein by insulin. J. Clin. Endocrinol. Metab., 68, 135-140.
82. Taylor, A.K., Lueken, S.A., Libanati, C. and Baylink, D.J. (1994) Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum. Dis. Clin. N. Am., 20, 589-607.
83. Telleria, C.M., Ou, J., Sugino, N. et al. (1998) The expression of interleukin-6 in the pregnant rat corpus luteum and its regulation by progesterone and glucocorticoid. Endocrinology, 139, 3597-3605.
84. Trautman, P.D., Meyer, Bahlburg, H.F.L. et al. (1995) Effects of early prenatal dexamethasone on the cognitive and behavioural development of young children: results of a pilot study. Psychoneuroendocrinology, 439-449.
85. Tuimala, R., Kauppila, A. and Ylikorkala, O. (1975) Effect of dexamethasone on blood glucose, serum insulin, free fatty acid and triglyceride levels during the last trimester of pregnancy. Int. J. Gynaecol. Obstet., 13, 81-84.
86. Unterman, T.G. and Phillips, L.S. (1985) Glucocorticoid effects on somatomedins and somatomedin inhibitors. J. Clin. Endocrinol. Metab., 61, 618-626.
87. Wallace, E.M. and Baker, L.S. (1999) Effect of betamethasone administration on placental vascular resistance. Lancet, 353, 1404-1407.
88. Wang, H.S. and Chard, T. (1992) The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth. J. Endocrinol., 132, 11-19.
89. Wang, H.S., Perry, L.A., Kanisius, J. et al. (1991) Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy. J. Endocrinol., 128, 161-168.
90. th week of pregnancy. J. Endocrinol., 61, 75-81.
91. Wilson, E.A. and Jawad, M.J. (1982) Stimulation of human chorionic gonadotrophin secretion by glucocorticoids. Am. J. Obstet. Gynecol., 142, 344-349.
92. Ylikorkala, O. and Kauppila, A. (1974) Effect of dexamethasone on serum levels of human placental lactogen during the last trimester of pregnancy. J. Obstet. Gynaecol. Br. Commonw., 81, 368-370.
93. Ylikorkala, O., Dawood, M.Y., Kauppila, A. and Tuimala, R. (1978) Effects of maternal Dexamethasone therapy on the Levels of oestrogens, progesterone and chorionic gonadotrophin in amniotic fluid and maternal serum. Br. J. Obstet. Gynaecol., 85, 334-337.